Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited

PBIGF
Paradigm Biopharmaceuticals LimitedUS flagOther OTC
0.13
USD
- -
- -
79.15MMarket Cap

Total Valuation

Paradigm Biopharmaceuticals Limited carries a market capitalization of 79.15M, placing it among publicly traded companies globally.

Market Cap79.15M
Enterprise ValueN/A

Stock Price Statistics

Paradigm Biopharmaceuticals Limited's stock has declined approximately -22.29412% over the past 52 weeks. The 50-day moving average sits at 0.13, while the 200-day moving average is 0.18.

Beta (5Y)N/A
52-Week Price Change-22.29412%
50-Day Moving Average0.13
200-Day Moving Average0.18
Average Volume (20 Days)N/A

Stock Splits

Paradigm Biopharmaceuticals Limited's most recent stock split took place on November 1, 2023 with a 250:257 split ratio.

Last Split Date11/1/2023
Split Ratio250:257